Intuitive Surgical stock tumbled Wednesday after the robotic surgery giant issued a lackluster view for 2026 procedure growth ...

Over 3 million procedures were performed globally on Intuitive daVinci systems last year, accounting for an 18% increase.

ISRG posts strong preliminary Q4 and full-year 2025 revenue growth, but shares dip as investors weigh procedure trends, ...

Intuitive Surgical released specifics on its Ion platform, reporting 51% YoY growth in Ion procedures for 2025.

Intuitive Surgical Q4 2025 revenue rose 19% y/y; 2026 procedure guidance disappointed, but da Vinci 5 strength supports Buy—read now.

CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving ...

SUNNYVALE, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that ...

Intuitive Surgical is a leader in the field of surgical robotics. The company has 10,763 surgical robots in place worldwide. Its robots are seeing strong demand -- and that should continue. Innovation ...

The upcoming report from Intuitive Surgical, Inc. (ISRG) is expected to reveal quarterly earnings of $2.25 per share, ...

Intuitive's da Vinci SP surgical system receives FDA clearance for transanal local resection, enhancing minimally invasive colorectal surgery options. Intuitive, a leader in robotic-assisted surgery, ...

Intuitive Surgical (NASDAQ: ISRG) has rewarded long-term investors by climbing nearly 200% over the past five years. This is thanks to the company's leadership in a hot growth area: robotic surgery.

Intuitive's da Vinci 5 Surgical System receives CE mark approval for minimally invasive surgery in Europe, enhancing surgical capabilities and efficiency. Intuitive Surgical has announced that its da ...